Liposomal Amphotericin B in Invasive Aspergillosis With Hepatic Dysfunction
NCT07337720
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Aspergillosis Invasive
Interventions
DRUG:
LIposomal amphotericin B (L-AmB) treatment
Sponsor
Southeast University, China